From Veep to President
05.05.2015 - The Faculty of Pharmaceutical Medicine has reinforced its top ranks with the appointment of Professor Alan Boyd as its new President. Alan who is currently Vice President of the faculty, will take up office later this year on 19th November replacing Dr Keith Bragman who will have served a three-year term.
Alan is owner of Boyds consultancy business and began his pharmaceutical career 28 years ago at Glaxo Group Research Ltd. From 1988 he led ICI’s cardiovascular medical research team, later taking on the role of Director of Clinical and Medical Affairs at ICI Pharma in Canada. In 1999, after four years as Head of Medical Research for Zeneca Pharmaceuticals, he became Director of Research and Development for Ark Therapeutics Ltd where he was responsible for delivering the majority of key development milestones that have shaped the company. In April 2005, he left to set up Alan Boyd Consultants Ltd. The focus of the consultancy is to aid and support early stage life science based companies.
Alan is a graduate in Biochemistry and Medicine from the University of Birmingham. His experience will ensure that the Faculty will help further establish its role as a healthcare partner and in the outside world.http://www.european-biotechnology-news.com/people/bio-people/2015/alan-boyd.html